Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Ferrena

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Cancer Therapeutics|October 23, 2023
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable PrognosisAlexander Ferrena, Jichuan Wang, Ranxin Zhang, et al.
Cancer Research|August 11, 2022
Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell StateKenneth L Pitter, Olivera Grbovic-Huezo, Simon Joost, et al.
Cancer Research Communications|March 25, 2026
Single cell RNA analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathwayAlexander Ferrena, Ranxin Zhang, Jichuan Wang, et al.
Annals of the New York Academy of Sciences|February 17, 2021
The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcomaJichuan Wang, Osama Aldahamsheh, Alexander Ferrena, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
ERBB4 deficiency promotes atrial myopathy underlying the atrial fibrillation substrateNaoko Yamaguchi, John Santucci, Seok Jae Hong, et al.
Oncogene|February 14, 2024
Targeted inhibition of SCF<sup>SKP2</sup> confers anti-tumor activities resulting in a survival benefit in osteosarcomaJichuan Wang, Alexander Ferrena, Ranxin Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Aging limits stemness and tumorigenesis in the lung by reprogramming iron homeostasisXueqian Zhuang, Qing Wang, Simon Joost, et al.
Nature|December 5, 2024
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasisXueqian Zhuang, Qing Wang, Simon Joost, et al.
Nature|May 22, 2025
Publisher Correction: Ageing limits stemness and tumorigenesis by reprogramming iron homeostasisXueqian Zhuang, Qing Wang, Simon Joost, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Cancer Therapeutics|October 23, 2023
SKP2 Knockout in Rb1/p53-Deficient Mouse Models of Osteosarcoma Induces Immune Infiltration and Drives a Transcriptional Program with a Favorable PrognosisAlexander Ferrena, Jichuan Wang, Ranxin Zhang, et al.
Cancer Research|August 11, 2022
Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell StateKenneth L Pitter, Olivera Grbovic-Huezo, Simon Joost, et al.
Cancer Research Communications|March 25, 2026
Single cell RNA analysis of murine osteosarcoma uncovers Skp2 function in metastasis, genomic instability and immune activation and reveals additional target pathwayAlexander Ferrena, Ranxin Zhang, Jichuan Wang, et al.
Annals of the New York Academy of Sciences|February 17, 2021
The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcomaJichuan Wang, Osama Aldahamsheh, Alexander Ferrena, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
ERBB4 deficiency promotes atrial myopathy underlying the atrial fibrillation substrateNaoko Yamaguchi, John Santucci, Seok Jae Hong, et al.
Oncogene|February 14, 2024
Targeted inhibition of SCF<sup>SKP2</sup> confers anti-tumor activities resulting in a survival benefit in osteosarcomaJichuan Wang, Alexander Ferrena, Ranxin Zhang, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Aging limits stemness and tumorigenesis in the lung by reprogramming iron homeostasisXueqian Zhuang, Qing Wang, Simon Joost, et al.
Nature|December 5, 2024
Ageing limits stemness and tumorigenesis by reprogramming iron homeostasisXueqian Zhuang, Qing Wang, Simon Joost, et al.
Nature|May 22, 2025
Publisher Correction: Ageing limits stemness and tumorigenesis by reprogramming iron homeostasisXueqian Zhuang, Qing Wang, Simon Joost, et al.
Pageof 2